ALPS Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.2M | Sell |
1,040,005
-2,072
| -0.2% | -$55.2K | 0.14% | 82 |
|
|
2025
Q4 | $25.9M | Sell |
1,042,077
-57,526
| -5% | -$1.45M | 0.15% | 82 |
|
|
2025
Q3 | $28M | Buy |
1,099,603
+128,134
| +13% | +$3.16M | 0.16% | 68 |
|
|
2025
Q2 | $23.5M | Buy |
971,469
+18,359
| +2% | +$428K | 0.14% | 94 |
|
|
2025
Q1 | $24.2M | Buy |
953,110
+6,057
| +0.6% | +$158K | 0.14% | 91 |
|
|
2024
Q4 | $25.1M | Buy |
947,053
+123,766
| +15% | +$3.36M | 0.16% | 68 |
|
|
2024
Q3 | $23.8M | Sell |
823,287
-227,659
| -22% | -$6.64M | 0.16% | 98 |
|
|
2024
Q2 | $29.4M | Sell |
1,050,946
-33,868
| -3% | -$932K | 0.2% | 55 |
|
|
2024
Q1 | $30.1M | Buy |
1,084,814
+56,508
| +5% | +$1.57M | 0.21% | 53 |
|
|
2023
Q4 | $29.6M | Buy |
1,028,306
+764,256
| +289% | +$23.1M | 0.23% | 53 |
|
|
2023
Q3 | $8.76M | Sell |
264,050
-315,424
| -54% | -$11.2M | 0.07% | 142 |
|
|
2023
Q2 | $21.3M | Sell |
579,474
-12,446
| -2% | -$484K | 0.18% | 108 |
|
|
2023
Q1 | $24.2M | Sell |
591,920
-25,257
| -4% | -$1.09M | 0.21% | 97 |
|
|
2022
Q4 | $31.6M | Sell |
617,177
-32,588
| -5% | -$1.56M | 0.28% | 40 |
|
|
2022
Q3 | $28.4M | Buy |
649,765
+35,730
| +6% | +$1.74M | 0.27% | 51 |
|
|
2022
Q2 | $32.2M | Buy |
614,035
+553,029
| +907% | +$28.2M | 0.31% | 43 |
|
|
2022
Q1 | $3.16M | Sell |
61,006
-8,050
| -12% | -$418K | 0.03% | 159 |
|
|
2021
Q4 | $4.08M | Sell |
69,056
-1,872,788
| -96% | -$92.8M | 0.05% | 163 |
|
|
2021
Q3 | $83.5M | Sell |
1,941,844
-120,317
| -6% | -$5.33M | 0.8% | 24 |
|
|
2021
Q2 | $80.8M | Buy |
2,062,161
+536,392
| +35% | +$20.9M | 0.71% | 24 |
|
|
2021
Q1 | $55.3M | Buy |
1,525,769
+154,669
| +11% | +$5.49M | 0.54% | 34 |
|
|
2020
Q4 | $50.5M | Sell |
1,371,100
-82,341
| -6% | -$3.02M | 0.57% | 30 |
|
|
2020
Q3 | $50.6M | Sell |
1,453,441
-115,340
| -7% | -$4.04M | 0.75% | 26 |
|
|
2020
Q2 | $48.7M | Sell |
1,568,781
-85,995
| -5% | -$2.92M | 0.65% | 28 |
|
|
2020
Q1 | $51.2M | Sell |
1,654,776
-223,917
| -12% | -$7.63M | 0.79% | 22 |
|
|
2019
Q4 | $69.8M | Sell |
1,878,693
-38,264
| -2% | -$1.36M | 0.54% | 28 |
|
|
2019
Q3 | $65.3M | Buy |
1,916,957
+115,539
| +6% | +$4.2M | 0.51% | 28 |
|
|
2019
Q2 | $74M | Sell |
1,801,418
-509,133
| -22% | -$20.2M | 0.55% | 29 |
|
|
2019
Q1 | $93.1M | Buy |
2,310,551
+67,244
| +3% | +$2.69M | 0.66% | 28 |
|
|
2018
Q4 | $92.9M | Sell |
2,243,307
-219,239
| -9% | -$9.1M | 0.72% | 28 |
|
|
2018
Q3 | $103M | Sell |
2,462,546
-260,739
| -10% | -$10M | 0.68% | 30 |
|
|
2018
Q2 | $93.7M | Buy |
2,723,285
+1,231,207
| +83% | +$42.1M | 0.61% | 35 |
|
|
2018
Q1 | $50.2M | Buy |
1,492,078
+30,919
| +2% | +$1.06M | 0.4% | 42 |
|
|
2017
Q4 | $50.2M | Buy |
1,461,159
+28,847
| +2% | +$984K | 0.35% | 48 |
|
|
2017
Q3 | $48.5M | Sell |
1,432,312
-98,330
| -6% | -$3.16M | 0.34% | 48 |
|
|
2017
Q2 | $48.8M | Buy |
1,530,642
+52,911
| +4% | +$1.67M | 0.34% | 35 |
|
|
2017
Q1 | $48M | Buy |
1,477,731
+204,399
| +16% | +$6.44M | 0.33% | 41 |
|
|
2016
Q4 | $39.2M | Buy |
1,273,332
+308,582
| +32% | +$9.42M | 0.29% | 38 |
|
|
2016
Q3 | $31M | Buy |
964,750
+178,013
| +23% | +$5.95M | 0.25% | 68 |
|
|
2016
Q2 | $26.3M | Buy |
786,737
+30,500
| +4% | +$973K | 0.23% | 60 |
|
|
2016
Q1 | $21.3M | Buy |
756,237
+113,187
| +18% | +$3.23M | 0.22% | 83 |
|
|
2015
Q4 | $19.7M | Buy |
643,050
+141
| +0% | +$4.44K | 0.19% | 81 |
|
|
2015
Q3 | $192K | Sell |
642,909
-128,695
| -17% | -$4.13M | 0.2% | 70 |
|
|
2015
Q2 | $24.5M | Buy |
771,604
+38,960
| +5% | +$1.27M | 0.21% | 62 |
|
|
2015
Q1 | $24.2M | Buy |
732,644
+21,796
| +3% | +$693K | 0.2% | 54 |
|
|
2014
Q4 | $21M | Buy |
710,848
+97,432
| +16% | +$2.79M | 0.17% | 74 |
|
|
2014
Q3 | $17.2M | Buy |
613,416
+90,032
| +17% | +$2.53M | 0.13% | 57 |
|
|
2014
Q2 | $14.7M | Buy |
523,384
+148,692
| +40% | +$4.24M | 0.13% | 66 |
|
|
2014
Q1 | $11.4M | Buy |
374,692
+28,703
| +8% | +$856K | 0.11% | 81 |
|
|
2013
Q4 | $9.98M | Buy |
345,989
+54,101
| +19% | +$1.57M | 0.1% | 69 |
|
|
2013
Q3 | $7.95M | Buy |
291,888
+87,263
| +43% | +$2.37M | 0.09% | 74 |
|
|
2013
Q2 | $5.44M | Buy |
+204,625
| New | +$5.65M | 0.07% | 81 |
|
Other funds holding PFE
VCM
VPM
ALPS Advisors's PFE Position: Q1 2026 in Review
ALPS Advisors reduced its Pfizer (PFE) stake by 0.2% in Q1 2026, selling an estimated $55.2K and leaving 1,040,005 shares worth $29.2M. The position accounts for 0.14% of the portfolio, ranked #82.
ALPS Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q3 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- ALPS Advisors held 1,040,005 shares of Pfizer worth $29.2M as of Q1 2026.
- ALPS Advisors sold 2,072 Pfizer shares in Q1 2026, an estimated $55.2K.
- Pfizer made up 0.14% of ALPS Advisors's portfolio in Q1 2026, its #82 holding.
- ALPS Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- ALPS Advisors's Pfizer position peaked at $103M in Q3 2018.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.